Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
暂无分享,去创建一个
H. Schünemann | E. Novellino | J. Bousquet | C. Bachert | G. Canonica | J. Fonseca | T. Haahtela | B. Samoliński | P. Kuna | A. Bedbrook | S. Bosnic-Anticevich | K. Boussery | V. Briedis | E. Menditto | D. Wallace | B. Cvetkovski | R. Tan | V. Kritikos | E. Costa | O. Lourenço | Sophie Scheire | S. Białek | S. Scheire | Rachel Tan | Walter Canonica | Walter Canonica | J. Bousquet | S. Bosnic‐Anticevich
[1] A. Sheikh,et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases , 2019, Clinical and Translational Allergy.
[2] K. Tsai,et al. Impact of Computer‐Based and Pharmacist‐Assisted Medication Review Initiated in the Emergency Department , 2019, Journal of the American Geriatrics Society.
[3] Airways ICPs initiative,et al. ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project , 2019 .
[4] A. Sheikh,et al. 2019 ARIA Care pathways for allergen immunotherapy , 2019, Allergy.
[5] A. Sheikh,et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study , 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[6] A. Sheikh,et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma , 2019, Clinical and Translational Allergy.
[7] A. Sheikh,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. , 2019, The Journal of allergy and clinical immunology.
[8] N. Dattani,et al. Chronic rhinosinusitis , 2019, British Medical Journal.
[9] J. Bousquet,et al. Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases , 2019, Clinical and Translational Allergy.
[10] D. Price,et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. , 2019, The Journal of allergy and clinical immunology.
[11] Todor A Popov,et al. ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy” , 2019, Allergy.
[12] Rosalind W. Picard,et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence , 2018, Clinical and Translational Allergy.
[13] P. Gevaert,et al. What treatments are effective for common cold in adults and children? , 2018, British Medical Journal.
[14] Przemyslaw Kardas,et al. Adherence to chronic medication in older populations: application of a common protocol among three European cohorts , 2018, Patient preference and adherence.
[15] K. W. Ruud,et al. Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies. , 2018, Patient education and counseling.
[16] D. Price,et al. The Burden of Rhinitis and the Impact of Medication Management within the Community Pharmacy Setting. , 2018, The journal of allergy and clinical immunology. In practice.
[17] Boleslaw Samolinski,et al. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] A. Sheikh,et al. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study , 2018, Allergy.
[19] P. Ribó,et al. Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort , 2018, Clinical and Translational Allergy.
[20] J. Bousquet,et al. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management , 2018, Clinical and Translational Allergy.
[21] J. Harrison,et al. Community pharmacist‐led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review , 2018, The International journal of pharmacy practice.
[22] D. Ryan,et al. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia , 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.
[23] A. Sheikh,et al. 国际过敏与鼻科学共识声明 : 变应性鼻炎 , 2018 .
[24] A. Sheikh,et al. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study , 2018, Allergy.
[25] Sinthia Bosnic-Anticevich,et al. Tell me about your hay fever: a qualitative investigation of allergic rhinitis management from the perspective of the patient , 2018, npj Primary Care Respiratory Medicine.
[26] Stephen R. Williams,et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project) , 2018, Allergy.
[27] P. Cullinan,et al. Impact of Rhinitis on Work Productivity: A Systematic Review. , 2017, The journal of allergy and clinical immunology. In practice.
[28] W. Dolen,et al. Management of Allergic Rhinitis: A Review for the Community Pharmacist. , 2017, Clinical therapeutics.
[29] D. Price,et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon , 2017, Asthma Research and Practice.
[30] M. Shakeel,et al. Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey , 2017, The Journal of Laryngology & Otology.
[31] Joaquim Mullol,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision , 2017, The Journal of allergy and clinical immunology.
[32] J. Bousquet,et al. Work productivity in rhinitis using cell phones: The MASK pilot study , 2017, Allergy.
[33] P. Frith,et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. , 2017, The Cochrane database of systematic reviews.
[34] D. Wallace,et al. Seasonal Allergic Rhinitis: A focused systematic review and practice parameter update. , 2017, Current opinion in allergy and clinical immunology.
[35] R. Gaudin,et al. Association between Symptoms of Allergic Rhinitis with Decreased General Health–Related Quality of Life , 2017, American journal of rhinology & allergy.
[36] Margaret McCann,et al. Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease. , 2017, The Cochrane database of systematic reviews.
[37] Todor A Popov,et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle , 2016, Clinical and Translational Allergy.
[38] Aravinda Thiagalingam,et al. Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps , 2016, JMIR mHealth and uHealth.
[39] Ş. Apikoglu-Rabus,et al. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. , 2016, Respiratory medicine.
[40] C. Rhee,et al. A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis , 2016, Allergy & rhinology.
[41] Robert W. Grundmeier,et al. The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study , 2016, BMC Pediatrics.
[42] D. Postma,et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) , 2016, Clinical and Translational Allergy.
[43] E. Meltzer. Allergic Rhinitis: Burden of Illness, Quality of Life, Comorbidities, and Control. , 2016, Immunology and allergy clinics of North America.
[44] S. Nyenhuis,et al. Rhinitis in the Elderly. , 2016, Immunology and allergy clinics of North America.
[45] J. Bousquet,et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation , 2016, European Respiratory Journal.
[46] M. Woodward,et al. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. , 2016, JAMA internal medicine.
[47] L. Cardell,et al. TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study , 2016, npj Primary Care Respiratory Medicine.
[48] K. Rascati,et al. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma , 2015, Journal of managed care & specialty pharmacy.
[49] A. Leonardi,et al. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study , 2015, Current opinion in allergy and clinical immunology.
[50] T. Kyle,et al. Understanding the role of the healthcare professional in patient self-management of allergic rhinitis , 2015, SAGE open medicine.
[51] G. Canonica,et al. The patient with rhinitis in the pharmacy. A cross-sectional study in real life , 2015, Asthma Research and Practice.
[52] Hilary Pinnock,et al. Supported self-management for asthma , 2015, Breathe.
[53] J. Bousquet,et al. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps , 2015, Expert opinion on pharmacotherapy.
[54] Sonya Malekzadeh,et al. Clinical Practice Guideline , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[55] P. Grady,et al. Self-management: a comprehensive approach to management of chronic conditions. , 2014, American journal of public health.
[56] J. Bousquet,et al. MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis. , 2015, World hospitals and health services : the official journal of the International Hospital Federation.
[57] J. Mims. Epidemiology of allergic rhinitis , 2014, International forum of allergy & rhinology.
[58] D. Postma,et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) , 2014, European Respiratory Journal.
[59] G. Rachelefsky,et al. Are you comfortable with over-the-counter intranasal steroids for children? A call to action. , 2014, The journal of allergy and clinical immunology. In practice.
[60] J. Fonseca,et al. Evaluation of Allergic Rhinitis and Asthma Control in a Portuguese Community Pharmacy Setting , 2014, Journal of managed care & specialty pharmacy.
[61] J. Remon,et al. Self-medication in persistent rhinitis: overuse of decongestants in half of the patients. , 2014, The journal of allergy and clinical immunology. In practice.
[62] J. Remon,et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. , 2014, British journal of clinical pharmacology.
[63] Sandra C. Jones,et al. Asthma self management in adults: a review of current literature. , 2014, Collegian.
[64] Jacqueline A. Ross,et al. Intranasal corticosteroids: the role of patient preference and satisfaction. , 2014, Allergy and asthma proceedings.
[65] N. Papadopoulos,et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology , 2013, Allergy.
[66] J. Bousquet,et al. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[67] Tiago Jacinto,et al. Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care , 2013, Primary care respiratory journal : journal of the General Practice Airways Group.
[68] F. García Lizana. [European Innovation Partnership on active and healthy ageing]. , 2013, Medicina clinica.
[69] Sima Ajami,et al. Evaluate the ability of clinical decision support systems (CDSSs) to improve clinical practice. , 2013, Medical archives.
[70] J. Bousquet,et al. Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care , 2012, International Archives of Allergy and Immunology.
[71] R. Naclerio,et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. , 2012, Allergy and asthma proceedings.
[72] H. Goossens,et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. , 2012, Rhinology.
[73] Azelastine/fluticasone propionate(Dymista) for seasonal allergic rhinitis. , 2012, The Medical letter on drugs and therapeutics.
[74] Simon P. W. Schmitt,et al. Assessment of a computerised decision support system for allergic rhino-conjunctivitis counselling in German pharmacy , 2012, International Journal of Clinical Pharmacy.
[75] G. Ciprandi,et al. Impact of Allergic Rhinitis on Bronchi: An 8-year Follow-up Study , 2011, American journal of rhinology & allergy.
[76] J. Bousquet,et al. Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. , 2010, The Journal of allergy and clinical immunology.
[77] J. Sheppard,et al. Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis , 2010, Clinical ophthalmology.
[78] Holger J Schünemann,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. , 2010, The Journal of allergy and clinical immunology.
[79] G. Scadding,et al. Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline. , 2010, Primary care respiratory journal : journal of the General Practice Airways Group.
[80] M. Rottem. [Allergic rhinitis and its impact on asthma]. , 2010, Harefuah.
[81] J. Bousquet,et al. Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.
[82] J. Virchow,et al. Persistence with asthma treatment is low in Germany especially for controller medication – a population based study of 483 051 patients , 2010, Allergy.
[83] E. Meltzer,et al. Treatment of congestion in upper respiratory diseases , 2010, International journal of general medicine.
[84] M. Blaiss,et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[85] D. Price,et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. , 2009, Primary care respiratory journal : journal of the General Practice Airways Group.
[86] G. Scadding,et al. Is reliance on self‐medication and pharmacy care adequate for rhinitis patients? , 2009, International journal of clinical practice.
[87] Yoon Kim,et al. Evaluation of a computer-based adverse-drug-event monitor. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[88] D. Jarvis,et al. Rhinitis and onset of asthma: a longitudinal population-based study , 2008, The Lancet.
[89] S. Spector,et al. The diagnosis and management of rhinitis: an updated practice parameter. , 2008, The Journal of allergy and clinical immunology.
[90] B. Lambrecht,et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper , 2008, Allergy.
[91] G. Viegi,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.
[92] S. Bosnic-Anticevich,et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. , 2008, Patient education and counseling.
[93] S. Quirce,et al. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. , 2008, Journal of investigational allergology & clinical immunology.
[94] J. Bousquet,et al. Original article: Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines , 2007, Allergy.
[95] L. Mackeigan,et al. When Does Pharmaceutical Care Impact Health Outcomes? A Comparison of Community Pharmacy—Based Studies of Pharmaceutical Care for Patients with Asthma , 2005, The Annals of pharmacotherapy.
[96] Peter Graf. Rhinitis Medicamentosa , 2005, Treatments in respiratory medicine.
[97] W. Churchill,et al. Computer-based system for preventing adverse drug events. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[98] P. Howarth,et al. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy , 2004, Allergy.
[99] J. Bousquet,et al. Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.
[100] J Bousquet,et al. Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.
[101] M. J. Black,et al. Rhinitis medicamentosa. , 1980, Canadian Medical Association journal.